Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
849.43B
Market cap849.43B
Price-Earnings ratio
75.57
Price-Earnings ratio75.57
Dividend yield
0.61%
Dividend yield0.61%
Average volume
3.80M
Average volume3.80M
High today
$902.50
High today$902.50
Low today
$880.02
Low today$880.02
Open price
$886.40
Open price$886.40
Volume
4.30M
Volume4.30M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

Benzinga 2h
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?

Eli Lilly And Co LLY will be reporting its first-quarter earnings on Thursday. Wall Street expects $3.05 in EPS and $12.67 billion in revenues as the company re...

Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Seeking Alpha 7h
Eli Lilly Q1 2025 Earnings Preview

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Street Expectations Analysts expect the...

Eli Lilly Q1 2025 Earnings Preview
Benzinga 1d
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

Eli Lilly And Co LLY is scheduled to report its quarterly results on Thursday. The company is likely to report its first-quarter results in line with peers, wi...

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
10.3%
Sell
3.4%

More LLY News

Seeking Alpha 1d
WeightWatchers rises on partnership to offer Eli Lilly's Zepbound

Shares of WW International (NASDAQ:WW), jumped on Tuesday after the firm, formerly called WeightWatchers, partnered with Eli Lilly’s (NYSE:LLY) LillyDirect phar...

WeightWatchers rises on partnership to offer Eli Lilly's Zepbound
TipRanks 1d
Is Eli Lilly Stock a Buy Ahead of Earnings Despite a Rare Downgrade?

Eli Lilly (LLY) reports first-quarter earnings this Wednesday, May 1, and Wall Street will be picking apart every number. Revenue is expected to hit $12.67 bill...

Benzinga 2d
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications

A personal injury lawsuit was filed seeking damages against Eli Lilly And Co LLY, Johnson & Johnson JNJ and Kaiser Permanente, alleging their antipsychotic medi...

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications
TipRanks 2d
Eli Lilly downgraded to Reduce from Buy at HSBC

HSBC double downgraded Eli Lilly (LLY) to Reduce from Buy with a price target of $700, down from $1,150. The market has assumed a significant market share for L...

TipRanks 5d
Eli Lilly Stock is Stronger as it Fights for Alzheimer’s Drug Approval in Europe

Shares in pharmaceuticals giant Eli Lilly (LLY) were looking perkier today after it ramped up its battle to get a key Alzheimer’s drug given the green light in...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.